Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06IPT
|
|||
Former ID |
DNC009430
|
|||
Drug Name |
N-(Biphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide
|
|||
Synonyms |
(2z)-N-Biphenyl-4-Yl-2-Cyano-3-Hydroxybut-2-Enamide; CHEMBL519160; DB07443; (2Z)-2-cyano-3-hydroxy-N-(4-phenylphenyl)but-2-enamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H14N2O2
|
|||
Canonical SMILES |
CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C2=CC=CC=C2)O
|
|||
InChI |
1S/C17H14N2O2/c1-12(20)16(11-18)17(21)19-15-9-7-14(8-10-15)13-5-3-2-4-6-13/h2-10,20H,1H3,(H,19,21)/b16-12-
|
|||
InChIKey |
MUVPBAIVOHJDOC-VBKFSLOCSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Plasmodium Dihydroorotate dehydrogenase (Malaria DHOdehase) | Target Info | Inhibitor | [1] |
KEGG Pathway | Pyrimidine metabolism | |||
Metabolic pathways | ||||
Pathwhiz Pathway | Pyrimidine Metabolism | |||
Reactome | Pyrimidine biosynthesis | |||
WikiPathways | Metabolism of nucleotides |
References | Top | |||
---|---|---|---|---|
REF 1 | Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases. J Med Chem. 2009 May 14;52(9):2683-93. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.